- Report
- August 2024
- 175 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- October 2024
- 192 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 174 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- March 2025
- 175 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- May 2024
- 138 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 133 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 134 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 139 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 130 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- February 2021
- 420 Pages
United States
From €2047EUR$2,160USD£1,710GBP
€2275EUR$2,400USD£1,900GBP
- Report
- March 2025
- 92 Pages
China
From €1706EUR$1,800USD£1,425GBP
- Report
- August 2023
- 133 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1185EUR$1,250USD£990GBP
- Report
- July 2023
- 129 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Report
- May 2023
- 160 Pages
Global
From €4691EUR$4,949USD£3,919GBP
- Report
- August 2024
- 80 Pages
Japan
From €3317EUR$3,500USD£2,771GBP
- Report
- July 2023
- 214 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- March 2025
- 251 Pages
China
From €3791EUR$4,000USD£3,167GBP

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat mental disorders such as depression, obsessive-compulsive disorder (OCD), bulimia nervosa, and panic disorder. It is one of the most commonly prescribed drugs for mental disorders, and is available in both generic and brand-name formulations. Fluoxetine is also used to treat premenstrual dysphoric disorder (PMDD) and is sometimes used off-label to treat other conditions such as anxiety, bipolar disorder, and post-traumatic stress disorder (PTSD).
The Fluoxetine market is highly competitive, with a number of major pharmaceutical companies offering their own branded versions of the drug. These companies are engaged in research and development activities to develop new formulations and delivery systems for Fluoxetine. Additionally, generic versions of the drug are widely available, providing an affordable alternative for patients.
Some of the major companies in the Fluoxetine market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Mylan. Show Less Read more